Your browser doesn't support javascript.
loading
Study of stability and biophysical characterization of ranibizumab and aflibercept.
Moreno, M R; Tabitha, T S; Nirmal, J; Radhakrishnan, K; Yee, C H; Lim, S; Venkatraman, S; Agrawal, R.
Affiliation
  • Moreno MR; School of Material Science & Engineering, Nanyang Technological University, Singapore. Electronic address: mmoreno@ntu.edu.sg.
  • Tabitha TS; School of Material Science & Engineering, Nanyang Technological University, Singapore.
  • Nirmal J; School of Material Science & Engineering, Nanyang Technological University, Singapore.
  • Radhakrishnan K; School of Material Science & Engineering, Nanyang Technological University, Singapore.
  • Yee CH; School of Material Science & Engineering, Nanyang Technological University, Singapore.
  • Lim S; School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore.
  • Venkatraman S; School of Material Science & Engineering, Nanyang Technological University, Singapore.
  • Agrawal R; Tan Tock Seng Hospital, Singapore. Electronic address: rupesh_agrawal@ttsh.com.sg.
Eur J Pharm Biopharm ; 108: 156-167, 2016 Nov.
Article in En | MEDLINE | ID: mdl-27615995
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Receptors, Vascular Endothelial Growth Factor / Drug Stability / Ranibizumab Limits: Humans Language: En Journal: Eur J Pharm Biopharm Journal subject: FARMACIA / FARMACOLOGIA Year: 2016 Document type: Article Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Receptors, Vascular Endothelial Growth Factor / Drug Stability / Ranibizumab Limits: Humans Language: En Journal: Eur J Pharm Biopharm Journal subject: FARMACIA / FARMACOLOGIA Year: 2016 Document type: Article Country of publication: Netherlands